Accelerating Healthcare Solutions with B2B eCommerce

WASHINGTON – AdvaMed, the Medtech Association, today commended Senators Mike Rounds (R-SD) and Martin Heinrich (D-NM) for introducing the Health Tech Investment Act (S. 1399). This landmark bipartisan legislation will establish a stable reimbursement pathway for medical devices authorized by the U.S. Food & Drug Administration (FDA) that rely on artificial intelligence (AI) and machine learning (ML), also known as Algorithm-Based Healthcare Services (ABHS).

Details a sweeping tariff hike to 84% on Chinese imports and de minimis increases, aiming to protect U.S. economic and national security.

Each year, L.E.K. surveys approximately 200 senior hospital executives and administrators to uncover key strategic priorities, trends, challenges, and opportunities in the healthcare industry. Join the L.E.K. Medtech team as we share these valuable insights and discuss what this means for MedTech companies.

The use of ePTFE in medical devices has enormous advantages, but getting it right requires deep expertise. Join us as we explore the benefits, risks, and mitigation strategies, along with innovative processing approaches that unlock its full potential.

Exclusive member webinar on tariffs, customs, USMCA rules of origin, and compliance strategies with expert Larry Friedman. Air Date April 4, 2025. Now On Demand!

Discover how AI is transforming medical technology with the AI Policy Roadmap. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!

Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.

Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.